Cancer in Oklahoma data brief series: Prostate cancer in Oklahoma

In 2018, prostate cancer was the most diagnosed cancer and the second leading cause of death from cancer among men in the United States (106.8 cases/100,000 and 7.8 deaths/100,000) and in Oklahoma (95.7 cases/100,000 and 8.4 deaths/100,000). Nationally, Oklahoma ranks 39th worst among all states in prostate cancer incidence and 13th worst in overall prostate cancer mortality. Prostate cancer screening through prostate specific antigen (PSA) testing maintains a “C”, recommending selectively offering the test, a recommendation from the United State Preventative Task Force (USPSTF). The USPSTF suggestion for practice is “to offer or provide this service for selected patients depending on individual circumstances.” No recent reports have summarized cancer screening, incidence, and mortality rates for prostate cancer in Oklahoma. The goal of this data brief is to describe prostate screening, incidence, and mortality rates among men in the state. This brief concludes with a discussion of the significance of findings on clinical practice and public health policy. (author introduction) #P4HEwebinarFebruary2024